{"id":"NCT00490815","sponsor":"Alimera Sciences","briefTitle":"Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema","officialTitle":"An Open Label Pharmacokinetic and Efficacy Study of 0.5 μg/Day and 0.2 μg/Day Fluocinolone Acetonide Intravitreal Inserts in Subjects With Diabetic Macular Edema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08","primaryCompletion":"2009-09","completion":"2011-04","firstPosted":"2007-06-25","resultsPosted":"2014-02-13","lastUpdate":"2014-02-13"},"enrollment":37,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Macular Edema"],"interventions":[{"type":"DRUG","name":"Fluocinolone Acetonide","otherNames":[]},{"type":"DRUG","name":"Fluocinolone Acetonide","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the pharmacokinetics, safety and efficacy of an intravitreal insert of fluocinolone acetonide for the treatment of diabetic macular edema","primaryOutcome":{"measure":"Levels of Fluocinolone Acetonide in Plasma and Aqueous Humor","timeFrame":"over 36 months","effectByArm":[{"arm":"Fluocinolone Acetonide: 0.2 ug/Day Implant","deltaMin":1.4905,"sd":1.87058},{"arm":"Fluocinolone Acetonide: 0.5 ug/Day Implant","deltaMin":0.714,"sd":0.78096}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":20},"commonTop":["Cataract","Conjunctival haemorrhage","Myodesopsia","Intraocular pressure increased","Cataract"]}}